An international team of scientists has shown that more than 80 per cent of bowel cancers could be treated with existing drugs. The study found that medicines called ‘JAK inhibitors’ halted tumour growth in bowel cancers with a genetic mutation that is present in more than 80 per cent of bowel cancers. Multiple JAK inhibitors are currently used, or are in clinical trials, for diseases including rheumatoid arthritis, psoriasis, blood cancers and myeloproliferative disorders.

READ FULL ARTICLE Curated publisher From Medical Express